KR20180091007A - Vitamin Formulation - Google Patents
Vitamin Formulation Download PDFInfo
- Publication number
- KR20180091007A KR20180091007A KR1020187015954A KR20187015954A KR20180091007A KR 20180091007 A KR20180091007 A KR 20180091007A KR 1020187015954 A KR1020187015954 A KR 1020187015954A KR 20187015954 A KR20187015954 A KR 20187015954A KR 20180091007 A KR20180091007 A KR 20180091007A
- Authority
- KR
- South Korea
- Prior art keywords
- solid particles
- weight
- vitamin
- gum
- total weight
- Prior art date
Links
- 229940088594 vitamin Drugs 0.000 title claims abstract description 21
- 229930003231 vitamin Natural products 0.000 title claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 21
- 239000011782 vitamin Substances 0.000 title claims abstract description 21
- 150000003722 vitamin derivatives Chemical class 0.000 title claims description 20
- 239000000203 mixture Substances 0.000 title description 29
- 238000009472 formulation Methods 0.000 title description 7
- 239000002245 particle Substances 0.000 claims abstract description 109
- 239000007787 solid Substances 0.000 claims abstract description 81
- 238000000034 method Methods 0.000 claims description 25
- 229920000881 Modified starch Polymers 0.000 claims description 24
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 23
- 235000019426 modified starch Nutrition 0.000 claims description 23
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 22
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 22
- 235000013305 food Nutrition 0.000 claims description 22
- 229960000342 retinol acetate Drugs 0.000 claims description 22
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 22
- 235000019173 retinyl acetate Nutrition 0.000 claims description 22
- 239000011770 retinyl acetate Substances 0.000 claims description 22
- 239000004368 Modified starch Substances 0.000 claims description 19
- 239000003995 emulsifying agent Substances 0.000 claims description 16
- 239000007891 compressed tablet Substances 0.000 claims description 14
- 235000000346 sugar Nutrition 0.000 claims description 14
- 244000215068 Acacia senegal Species 0.000 claims description 9
- 229920000084 Gum arabic Polymers 0.000 claims description 9
- 235000010489 acacia gum Nutrition 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 7
- 235000006491 Acacia senegal Nutrition 0.000 claims description 6
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 6
- 235000010980 cellulose Nutrition 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 6
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 5
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 5
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 5
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 5
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 150000004665 fatty acids Chemical class 0.000 claims description 5
- 235000004426 flaxseed Nutrition 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 241000251468 Actinopterygii Species 0.000 claims description 3
- 239000001904 Arabinogalactan Substances 0.000 claims description 3
- 229920000189 Arabinogalactan Polymers 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 3
- 240000002791 Brassica napus Species 0.000 claims description 3
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 3
- 244000020518 Carthamus tinctorius Species 0.000 claims description 3
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 3
- 229920000742 Cotton Polymers 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 241000219146 Gossypium Species 0.000 claims description 3
- 244000020551 Helianthus annuus Species 0.000 claims description 3
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 3
- 240000005979 Hordeum vulgare Species 0.000 claims description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 3
- 244000017020 Ipomoea batatas Species 0.000 claims description 3
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 3
- 240000004322 Lens culinaris Species 0.000 claims description 3
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 claims description 3
- 229920001732 Lignosulfonate Polymers 0.000 claims description 3
- 240000003183 Manihot esculenta Species 0.000 claims description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 3
- 108010011756 Milk Proteins Proteins 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 3
- 240000004713 Pisum sativum Species 0.000 claims description 3
- 235000010582 Pisum sativum Nutrition 0.000 claims description 3
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims description 3
- 241000209056 Secale Species 0.000 claims description 3
- 235000007238 Secale cereale Nutrition 0.000 claims description 3
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 3
- 244000040738 Sesamum orientale Species 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 240000003829 Sorghum propinquum Species 0.000 claims description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 3
- 241000282887 Suidae Species 0.000 claims description 3
- 240000004584 Tamarindus indica Species 0.000 claims description 3
- 235000004298 Tamarindus indica Nutrition 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 108010046377 Whey Proteins Proteins 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 235000021120 animal protein Nutrition 0.000 claims description 3
- 235000019312 arabinogalactan Nutrition 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229920002301 cellulose acetate Polymers 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 235000019961 diglycerides of fatty acid Nutrition 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 235000021239 milk protein Nutrition 0.000 claims description 3
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 claims description 3
- 235000014571 nuts Nutrition 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 229920000223 polyglycerol Polymers 0.000 claims description 3
- 235000012015 potatoes Nutrition 0.000 claims description 3
- 244000144977 poultry Species 0.000 claims description 3
- 229940108325 retinyl palmitate Drugs 0.000 claims description 3
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 3
- 239000011769 retinyl palmitate Substances 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 235000021119 whey protein Nutrition 0.000 claims description 3
- 238000007906 compression Methods 0.000 abstract description 3
- 230000006835 compression Effects 0.000 abstract description 3
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 19
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 19
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 19
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 19
- 229920002261 Corn starch Polymers 0.000 description 15
- 239000008120 corn starch Substances 0.000 description 15
- 239000000839 emulsion Substances 0.000 description 12
- 239000003826 tablet Substances 0.000 description 11
- 239000000843 powder Substances 0.000 description 9
- 238000004945 emulsification Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 239000012467 final product Substances 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 6
- 229920002774 Maltodextrin Polymers 0.000 description 5
- 239000005913 Maltodextrin Substances 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 229940035034 maltodextrin Drugs 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 4
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 229960000984 tocofersolan Drugs 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- FUWLWBDNQPTINE-UHFFFAOYSA-N 3-tert-butyl-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)C(C(C)(C)C)=CC2=C1 FUWLWBDNQPTINE-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229920002148 Gellan gum Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- -1 ascorbic acid ester Chemical class 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 235000010492 gellan gum Nutrition 0.000 description 2
- 239000000216 gellan gum Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 150000002840 non-reducing disaccharides Chemical group 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000002266 vitamin A derivatives Chemical class 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
- A23L29/219—Chemically modified starch; Reaction or complexation products of starch with other chemicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/26—Food, ingredients or supplements targeted to meet non-medical requirements, e.g. environmental, religious
- A23V2200/264—All vegan ingredients, i.e. all animal product free
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/636—Trehalose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/702—Vitamin A
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Birds (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
본 특허 명세서는, 정제(tablet)로 압축 시에 더욱 안정적인, 하나 이상의 지용성 비타민을 포함하는 고체 입자에 관한 것이다. This patent specification relates to solid particles comprising one or more fat soluble vitamins which are more stable upon compression into tablets.
Description
본원은, 정제(tablet)로 압축 시에 더욱 안정적인, 하나 이상의 지용성 비타민을 고-함량으로 포함하는 고체 입자에 관한 것이다. 나아가, 상기 입자는 동물로부터 유래된 임의의 성분이 전혀 없고 따라서 채식주의자에게 적합할 수 있다.The present invention relates to a solid particle comprising, in a high-content, one or more fat soluble vitamins which are more stable upon compression into tablets. Furthermore, the particles are free of any components derived from animals and thus may be suitable for vegetarians.
압축된 정제는 지용성 비타민 투여에 아주 유용한 방법이다. 이들은 섭취하기 쉽고, 저장하기 쉬우며, 취급하기 좋다.Compressed tablets are a very useful method for administering fat-soluble vitamins. They are easy to ingest, easy to store, and good to handle.
압축된 정제가 제조되는 때에, 가혹한 조건이 적용되게 된다. 임의의 제형를 정제 형태로 압축하기 위해서는 특정 압력이 사용되어야 함이 분명하다. 따라서, 일반적으로는, 압축되는 데에 사용되는 제형의 일부분인 성분들이 스며나와서 더이상 정제의 일부분이 아니게 된다는 문제가 있다. 다시 말해 정제는 일반적으로, 압축된 정제에 압축된 제형보다 적은 지용성 비타민을 함유한다. 일반적으로 상기 지용성 비타민의 함량은 압축된 정제의 저장 도중에 점점 적어진다.When compressed tablets are produced, harsh conditions are applied. It is clear that certain pressures must be used to compress any formulation into tablet form. Thus, in general, there is a problem that the components that are part of the formulation used to be compressed exude and are no longer part of the tablet. In other words, tablets generally contain less fat soluble vitamins than compressed formulations in compressed tablets. In general, the content of the fat-soluble vitamin decreases gradually during storage of the compressed tablet.
지용성 비타민 제형화에 흔히 사용되는 젤라틴은 일반적으로, 동물 원료(source)로부터 유래되기 때문에 채식주의자에게 적합하지 않다.Gelatine, commonly used in fat-soluble vitamin formulations, is generally not suitable for vegetarians because it is derived from animal sources.
지용성 비타민을 포함하는 압축된 정제의 중요성으로 인해, 향상된 압축가능 제형이 항상 필요해왔다.Due to the importance of compressed tablets containing fat soluble vitamins, improved compressible formulations have always been needed.
놀랍게도, 압축된 정제 제조에 사용되는 고체 제형에 하나 이상의 비환원당(non-reducing sugar)을 첨가함으로써 그러한 향상이 달성될 수 있음이 발견되었다.Surprisingly, it has been found that such enhancement can be achieved by the addition of one or more non-reducing sugars to solid formulations used in the production of compressed tablets.
따라서, 본 발명은Therefore,
(i) 고체 입자의 총 중량을 기준으로 20 중량% 이상의 하나 이상의 지용성 비타민,(i) at least 20% by weight, based on the total weight of the solid particles, of at least one fat soluble vitamin,
(ii) 하나 이상의 유화제, 및(ii) at least one emulsifier, and
(iii) 하나 이상의 비환원당(non-reducing sugar)(iii) at least one non-reducing sugar,
을 포함하는 고체 입자(SP)에 관한 것이다.(SP). ≪ / RTI >
이 고체 입자는 정제로 압축 시에, (지용성 비타민의) 보다 나은 저장 안정성을 나타낸다.These solid particles exhibit better storage stability (of fat-soluble vitamins) when compressed into tablets.
또한, 단지 상기 3 종류의 성분으로만 고체 입자를 제조하는 것도 가능하다.In addition, it is also possible to produce solid particles only with the above three kinds of components.
따라서, 본 발명은Therefore,
(i) 고체 입자의 총 중량을 기준으로 20 중량% 이상의 하나 이상의 지용성 비타민,(i) at least 20% by weight, based on the total weight of the solid particles, of at least one fat soluble vitamin,
(ii) 하나 이상의 유화제, 및(ii) at least one emulsifier, and
(iii) 하나 이상의 비환원당(iii) one or more non-
으로 구성되는 고체 입자(SP')에 관한 것이다.(SP '). ≪ / RTI >
바람직한 비환원당은 비환원 이당류(disaccharide)이고; 더욱 바람직하게는 수크로스 및/또는 트레할로스, 가장 바람직하게는 트레할로스이다.A preferred non-reducing sugar is a non-reducing disaccharide; More preferably sucrose and / or trehalose, and most preferably trehalose.
수크로스는, 화학식 C12H22O11을 갖는, 단당류(monosaccharide) 글루코스와 프룩토스의 이당류 조합물이다. 이는 많은 공급처로부터 상업적으로 이용가능하다.Sucrose is a disaccharide combination of monosaccharide glucose and fructose having the formula C 12 H 22 O 11 . It is commercially available from many sources.
수크로스는 흔히, 인간용 사탕수수(cane) 또는 사탕무(beet)로부터 추출되고 정제된다.Sucrose is often extracted and purified from human cane or beet.
마이코스 또는 트레말로스로도 알려진 트레할로스는, 두 개의 α-글루코스 단위 사이의 α,α-1,1-글루코사이드 결합에 의해 형성된 천연 알파-결합형 이당류이다. 트레할로스가 옥수수 전분으로부터 유도되는 산업 공정이 있다. 트레할로스 생합성을 위한 생물학적 경로가 공지되어 있다.Trehalose, also known as mycose or tremolose, is a natural alpha-linked disaccharide formed by an alpha, alpha-1,1-glucoside bond between two alpha -glucose units. There is an industrial process in which trehalose is derived from corn starch. Biological pathways for trehalose biosynthesis are known.
트레할로스는 다양한 공급처로부터 상업적으로 이용가능하다Trehalose is commercially available from a variety of sources
상기 고체 입자 중 비환원당의 양은 고체 입자의 총 중량을 기준으로 5 내지 55 중량%이다. 바람직하게는, 고체 입자의 총 중량을 기준으로 10 내지 50 중량%이고; 더욱 바람직하게는 고체 입자의 총 중량을 기준으로 15 내지 45 중량%이다.The amount of non-reducing sugar in the solid particles is 5 to 55% by weight based on the total weight of the solid particles. Preferably 10 to 50% by weight, based on the total weight of the solid particles; More preferably 15 to 45% by weight based on the total weight of the solid particles.
따라서, 본 발명은, 고체 입자의 총 중량을 기준으로 5 내지 55 중량%의 하나 이상의 비환원당을 포함하는 고체 입자 (SP) 또는 (SP')인 고체 입자(SP1)에 관한 것이다.Accordingly, the present invention relates to solid particles (SP) or solid particles (SP ') comprising from 5 to 55% by weight, based on the total weight of the solid particles, of at least one non-reducing sugar.
따라서, 본 발명은, 고체 입자의 총 중량을 기준으로 10 내지 50 중량%의 하나 이상의 비환원당을 포함하는 고체 입자 (SP) 또는 (SP')인 고체 입자(SP2)에 관한 것이다.Accordingly, the present invention relates to solid particles (SP) or (SP ') comprising from 10 to 50% by weight, based on the total weight of the solid particles, of at least one non-reducing sugar.
따라서, 본 발명은, 고체 입자의 총 중량을 기준으로 15 내지 45 중량%의 하나 이상의 비환원당을 포함하는 고체 입자 (SP) 또는 (SP')인 고체 입자(SP3)에 관한 것이다.Accordingly, the present invention relates to solid particles (SP) or solid particles (SP ') comprising from 15 to 45% by weight, based on the total weight of the solid particles, of at least one non-reducing sugar.
본 발명에 따른 고체 입자는 하나 이상의 지용성 비타민을 포함한다.The solid particles according to the present invention comprise at least one fat soluble vitamin.
지용성 비타민은 비타민 A, D, E 및 K(뿐만 아니라 이들의 유도체)이다.Fat-soluble vitamins are vitamins A, D, E and K (as well as their derivatives).
본 발명의 바람직한 실시양태에서는, 비타민 A 및/또는 이의 유도체(예컨대 비타민 A 아세테이트 및 비타민 A 팔미테이트)가 사용된다.In a preferred embodiment of the present invention, vitamin A and / or derivatives thereof (e.g., vitamin A acetate and vitamin A palmitate) are used.
따라서, 본 발명은, 지용성 비타민이 비타민 A 및/또는 비타민 A의 유도체(특히 비타민 A 아세테이트 또는 비타민 A 팔미테이트)인 고체 입자 (SP), (SP'), (SP1) 또는 (SP2)인 고체 입자 (SP4)에 관한 것이다.Accordingly, the present invention relates to the use of a solid (SP), (SP '), (SP1) or (SP2) in which the fat soluble vitamin is a derivative of vitamin A and / or vitamin A (in particular vitamin A acetate or vitamin A palmitate) Particles SP4.
본 발명에 따른 고체 입자는 일반적으로, 고체 입자의 총 중량을 기준으로 20 내지 75 중량%, 바람직하게는 고체 입자의 총 중량을 기준으로 25 내지 70 중량%의 하나 이상의 지용성 비타민을 포함한다.The solid particles according to the invention generally comprise from 20 to 75% by weight, preferably from 25 to 70% by weight, based on the total weight of the solid particles, of a fat soluble vitamin, based on the total weight of the solid particles.
따라서, 본 발명은, 고체 입자가 고체 입자의 총 중량을 기준으로 20 내지 75 중량%의 지용성 비타민(들)을 포함하는, 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3) 또는 (SP4)인, 고체 입자 (SP5)에 관한 것이다.(SP), (SP1), (SP2), (SP2), and the like, wherein the solid particles comprise 20 to 75 weight percent of the fat soluble vitamin (s) based on the total weight of the solid particles. , (SP3) or (SP4).
따라서, 본 발명은, 고체 입자가 고체 입자의 총 중량을 기준으로 25 내지 70 중량%의 지용성 비타민(들)을 포함하는, 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4) 또는 (SP5)인, 고체 입자 (SP6)에 관한 것이다.(SP), (SP1 '), (SP2), (SP2), and the like, wherein the solid particles comprise 25 to 70 weight percent of the fat soluble vitamin (s) based on the total weight of the solid particles. , (SP3), (SP4) or (SP5).
나아가, 본 발명에 따른 고체 입자는 하나 이상의 유화제를 포함한다. 흔히 알려지고 사용되는 임의의 유화제가 사용될 수 있다. 단일 유화제뿐만 아니라 유화제의 혼합물이 사용될 수 있다.Further, the solid particles according to the present invention comprise at least one emulsifier. Any emulsifier that is commonly known and used may be used. Mixtures of emulsifiers as well as a single emulsifier may be used.
적합한 유화제는 식품용 변성 전분; 아스코르빌 팔미테이트; 펙틴; 알기네이트; 카라기닌; 푸르셀라란; 덱스트린 유도체; 셀룰로스 및 셀룰로스 유도체(예컨대 셀룰로스 아세테이트, 메틸 셀룰로스, 히드록시프로필 메틸 셀룰로스); 리그노술포네이트; 다당류 검(예컨대 검 아카시아(= 아라비아 고무), 변성 검 아카시아, TIC 검, 플랙씨드(flaxseed) 검, 가티 검, 타마린드 검 및 아라비노갈락탄); 젤라틴(소, 생선, 돼지, 가금류); 식물성 단백질(예컨대 예를 들면 완두콩, 대두, 피마자 콩, 목화, 감자, 고구마, 카사바, 평지씨, 해바라기, 참깨, 아마씨, 홍화씨, 렌틸, 견과, 밀, 쌀, 옥수수, 보리, 호밀, 귀리, 루핀 및 수수); 우유 또는 유청 단백질을 비롯한 동물성 단백질; 레시틴; 지방산의 폴리글리세롤 에스터; 지방산의 모노글리세리드; 지방산의 다이글리세리드; 소르비탄 에스터; 및 당 에스터(뿐만 아니라 이들의 유도체들)이다.Suitable emulsifiers include modified starches for foods; Ascorbyl palmitate; pectin; Alginate; Carrageenin; Furcellaran; Dextrin derivatives; Cellulose and cellulose derivatives (such as cellulose acetate, methylcellulose, hydroxypropylmethylcellulose); Lignosulfonates; Polysaccharide gums (for example, gum acacia (= gum arabic), modified gum acacia, TIC gum, flaxseed gum, guti gum, tamarind gum and arabinogalactan); Gelatin (cattle, fish, pigs, poultry); Vegetable protein such as peas, soybeans, cassia beans, cotton, potatoes, sweet potatoes, cassava, rapeseed, sunflower, sesame, flaxseed, safflower, lentils, nuts, wheat, rice, corn, barley, rye, And sorghum); Animal proteins, including milk or whey proteins; lecithin; Polyglycerol esters of fatty acids; Monoglycerides of fatty acids; Diglycerides of fatty acids; Sorbitan esters; And sugar esters (as well as derivatives thereof).
동물 원료로부터 유래되지 않은 유화제가 바람직하다.Emulsifiers not derived from animal sources are preferred.
더욱 바람직하게는, 식품용 변성 전분, 다당류(polysaccharide) 검 및 식물성 단백질이다.More preferably, it is a food modified starch, a polysaccharide gum and a vegetable protein.
상기 전분은 물리적으로 및 화학적으로 변성될 수 있다. 예비젤라틴화(pregelatinized) 전분은 물리적으로 변성된 전분의 예이다. 산-변성된, 산화된, 가교결합된, 전분 에스터, 전분 에터 및 양이온성 전분은 화학적으로 변성된 전분의 예이다.The starch may be physically and chemically modified. Pregelatinized starches are examples of physically modified starches. Acid-modified, oxidized, crosslinked, starch ester, starch ether and cationic starch are examples of chemically modified starches.
고체 입자 중 유화제(들)의 양은 일반적으로, 고체 입자의 총 중량을 기준으로 20 내지 75 중량%, 바람직하게는 고체 입자의 총 중량을 기준으로 25 내지 65 중량%이다.The amount of emulsifier (s) in the solid particles is generally from 20 to 75% by weight, preferably from 25 to 65% by weight, based on the total weight of the solid particles, based on the total weight of the solid particles.
따라서, 본 발명은, 상기 하나 이상의 유화제가 식품용 변성 전분; 아스코르빌 팔미테이트; 펙틴; 알기네이트; 카라기닌; 푸르셀라란; 덱스트린 유도체; 셀룰로스 및 셀룰로스 유도체(예컨대 셀룰로스 아세테이트, 메틸 셀룰로스, 히드록시프로필 메틸 셀룰로스); 리그노술포네이트; 다당류 검(예컨대 검 아카시아(= 아라비아 고무), 변성 검 아카시아, TIC 검, 플랙씨드 검, 가티 검, 타마린드 검 및 아라비노갈락탄); 젤라틴(소, 생선, 돼지, 가금류); 식물성 단백질(예컨대 예를 들면 완두콩, 대두, 피마자 콩, 목화, 감자, 고구마, 카사바, 평지씨, 해바라기, 참깨, 아마씨, 홍화씨, 렌틸, 견과, 밀, 쌀, 옥수수, 보리, 호밀, 귀리, 루핀 및 수수); 우유 또는 유청 단백질을 비롯한 동물성 단백질; 레시틴; 지방산의 폴리글리세롤 에스터; 지방산의 모노글리세리드; 지방산의 다이글리세리드; 소르비탄 에스터; 및 당 에스터(뿐만 아니라 이들의 유도체들)로 이루어진 군으로부터 선택되는, 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5) 또는 (SP6)인, 고체 입자 (SP7)에 관한 것이다.Accordingly, the present invention relates to the above-mentioned food composition, wherein said at least one emulsifier is a food modified starch; Ascorbyl palmitate; pectin; Alginate; Carrageenin; Furcellaran; Dextrin derivatives; Cellulose and cellulose derivatives (such as cellulose acetate, methylcellulose, hydroxypropylmethylcellulose); Lignosulfonates; Polysaccharide gums (e.g., gum acacia (= gum arabic), modified gum acacia, TIC gum, flaked gum, guti gum, tamarind gum and arabinogalactan); Gelatin (cattle, fish, pigs, poultry); Vegetable protein such as peas, soybeans, cassia beans, cotton, potatoes, sweet potatoes, cassava, rapeseed, sunflower, sesame, flaxseed, safflower, lentils, nuts, wheat, rice, corn, barley, rye, And sorghum); Animal proteins, including milk or whey proteins; lecithin; Polyglycerol esters of fatty acids; Monoglycerides of fatty acids; Diglycerides of fatty acids; Sorbitan esters; (SP), (SP1), (SP2), (SP3), (SP4), (SP5) or (SP5) SP6). ≪ / RTI >
따라서, 본 발명은, 상기 하나 이상의 유화제가 동물 원료로부터 유래되지 않은 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5) 또는 (SP6)인, 고체 입자 (SP7')에 관한 것이다.(SP), (SP), (SP1), (SP2), (SP3), (SP4), (SP5), or (SP6), which are not derived from animal feedstuffs, ), ≪ / RTI > solid particles (SP7 ').
따라서, 본 발명은, 상기 하나 이상의 유화제가 식품용 변성 전분, 다당류 검 및 식물성 단백질로 이루어진 군으로부터 선택되는, 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5) 또는 (SP6)인, 고체 입자 (SP7'')에 관한 것이다.(SP), (SP), (SP1), (SP2), (SP3) and (SP3), wherein the at least one emulsifier is selected from the group consisting of food modified starches, polysaccharide gums and vegetable proteins. , (SP4), (SP5) or (SP6).
따라서, 본 발명은, 고체 입자 중 상기 유화제(들)의 양이 고체 입자의 총 중량을 기준으로 20 내지 70 중량%인, 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6), (SP7), (SP7') 또는 (SP7'')인, 고체 입자 (SP8)에 관한 것이다.(SP), (SP '), (SP1), (SP2), and (SP2), wherein the amount of the emulsifier (s) in the solid particles is 20 to 70% by weight based on the total weight of the solid particles. , SP3, SP4, SP5, SP6, SP7, SP7 'or SP7 ".
따라서, 본 발명은, 고체 입자 중 상기 유화제(들)의 양이 고체 입자의 총 중량을 기준으로 25 내지 65 중량%인, 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6), (SP7), (SP7') 또는 (SP7'')인, 고체 입자 (SP9)에 관한 것이다.(SP), (SP '), (SP1), (SP2), and (SP2), wherein the amount of the emulsifier (s) in the solid particles is 25 to 65 wt.% Based on the total weight of the solid particles. , SP3, SP4, SP5, SP6, SP7, SP7 'or SP7 ".
나아가, 상기 고체 입자는 추가 성분(보조제)을 포함할 수 있다. 이러한 보조제는 예를 들면 항산화제(예컨대 아스코르브산 또는 이의 염, 토코페롤(합성 또는 천연), 부틸화 히드록시톨루엔(BHT), 아스코르빌 팔미테이트, 부틸화 히드록시아니솔(BHA), 프로필 갈레이트, tert-부틸 히드록시퀴놀린, 에톡시퀸 및/또는 지방산의 아스코르브산 에스터); 안정제(예컨대 잔탄 검, 젤란 검과 같은 겔-형성제); 습윤제(예컨대 글리세린, 소르비톨, 폴리에틸렌 글리콜); 염료; 향료; 충전제 및 완충제이다.Furthermore, the solid particles may comprise additional components (adjuvants). Such adjuvants include, for example, antioxidants such as ascorbic acid or its salts, tocopherol (synthetic or natural), butylated hydroxytoluene (BHT), ascorbyl palmitate, butylated hydroxyanisole (BHA) Ester, ascorbic acid ester of tert-butyl hydroxyquinoline, ethoxy queen and / or fatty acid); Stabilizers (such as xanthan gum, gel-forming agents such as gellan gum); Wetting agents (e.g., glycerin, sorbitol, polyethylene glycol); dyes; Spices; Fillers and buffers.
이들 보조제는 고체 입자, 이의 제조, 최종 제품(고체 입자가 사용된 것) 및/또는 최종 제품의 제조에 유용할 수 있다.These adjuvants may be useful in the preparation of solid particles, their preparation, the final product (in which solid particles are used) and / or the final product.
이들 화합물은 선택적으로, 고체 입자를 기준으로 15 중량% 이하의 양으로 사용될 수 있다.These compounds may optionally be used in an amount of up to 15% by weight based on the solid particles.
따라서, 본 발명은, 고체 입자를 기준으로 15 중량% 이하의 하나 이상의 보조제를 포함하는 고체 입자 (SP), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6), (SP7), (SP7'), (SP7''), (SP8) 또는 (SP9)인, 고체 입자 (SP10)에 관한 것이다.(SP), (SP2), (SP3), (SP4), (SP5), (SP6) ), (SP7), (SP7 '), (SP7' '), (SP8) or (SP9).
따라서, 본 발명은, 상기 보조제(또는 보조제들)가 항산화제(예컨대 아스코르브산 또는 이의 염, 토코페롤(합성 또는 천연), 부틸화 히드록시톨루엔(BHT), 아스코르빌 팔미테이트, 부틸화 히드록시아니솔(BHA), 프로필 갈레이트, tert-부틸 히드록시퀴놀린, 에톡시퀸 및/또는 지방산의 아스코르브산 에스터); 안정제(예컨대 잔탄 검, 젤란 검과 같은 겔-형성제); 습윤제(예컨대 글리세린, 소르비톨, 폴리에틸렌 글리콜); 염료; 향료; 충전제 및 완충제로 이루어진 군으로부터 선택되는, 고체 입자 (SP10)인, 고체 입자 (SP11)에 관한 것이다.Accordingly, the present invention is directed to a pharmaceutical composition wherein said adjuvant (or adjuvants) is an antioxidant (such as ascorbic acid or a salt thereof, tocopherol (synthetic or natural), butylated hydroxytoluene (BHT), ascorbyl palmitate, Ascorbic acid ester of anthol (BHA), propyl gallate, tert-butyl hydroxyquinoline, ethoxy queen and / or fatty acid); Stabilizers (such as xanthan gum, gel-forming agents such as gellan gum); Wetting agents (e.g., glycerin, sorbitol, polyethylene glycol); dyes; Spices; (SP11), wherein the solid particles (SP11) are selected from the group consisting of fillers and buffering agents.
본 발명에 따른 고체 입자의 제조 방법에 따라, 고체 입자가 분말 캐취 공정(powder catch process)에서 사용되는 분말로 코팅되는 것이 또한 가능하다. 이러한 분말은 예를 들면 옥수수 전분일 수 있다.According to the process for producing solid particles according to the present invention, it is also possible that the solid particles are coated with the powder used in the powder catch process. Such powders may be, for example, corn starch.
(특히 옥수수 전분의) 분말의 양은 분말 코팅된 입자의 총 중량을 기준으로 15 중량% 이하일 수 있다. 일반적으로는, 추가 코팅 층이 형성될 수 있도록, 분말 코팅의 함량은 가능한 한 낮게 유지된다.The amount of powder (especially of corn starch) may be up to 15% by weight based on the total weight of the powder coated particles. In general, the content of the powder coating is kept as low as possible so that an additional coating layer can be formed.
또한, 코팅 층으로 고체 입자를 코팅하는 것도 가능하다. 이 층은 공지되고 사용되는 임의의 코팅 물질로 이루어질 수 있다.It is also possible to coat the solid particles with the coating layer. This layer can be made of any known and used coating material.
본 발명의 고체 입자의 적합한 크기는 50 내지 1000 ㎛(바람직하게는 100 내지 800 ㎛)이고; 이 크기는 입자의 가장 긴 치수의 직경으로 정의되고 일반적으로 공지된 방법(예컨대 레이저 회절)으로 측정된다.A suitable size of the solid particles of the present invention is 50 to 1000 mu m (preferably 100 to 800 mu m); This size is defined as the diameter of the longest dimension of the particle and is generally measured by known methods (e.g., laser diffraction).
본 발명에 따른 고체 입자의 모든 입자 크기는, 영국의 맬베른 인스트루먼츠 리미티드(Malvern Instruments Ltd.)의 "마스터사이저(Mastersizer) 3000"를 사용한 레이저 회절 기술로 결정된다. 이 입자 크기 측정법에 대한 추가 정보는 예를 들면, 문헌["Basic principles of particle size analytics", Dr. Alan Rawle, Malvern Instruments Limited, Enigma Business Part, Grovewood Road, Malvern, Worcestershire, WR14 1XZ, UK] 및 "맬베른 입자 크기 분석기 매뉴얼(Manual of Malvern particle size analyzer)"에서 확인할 수 있다. 사용자 매뉴얼 "MAN 0096호 제1.0호, 1994, 11월"이 특히 참고되었다. 별도의 언급이 없다면, 본 발명에 따른 고체 입자의 조립 입자(coarse particle)에 대한 모든 입자 크기는 레이저 회절에 의해 결정된 Dv90 값(부피 직경, 이 지점 아래로 분포의 90%가 존재하고, 이 지점 위로 10%가 존재함)이다. 입자 크기는, 건조 형태(즉, 분말) 또는 현탁액 형태로 결정될 수 있다. 바람직하게는, 본 발명에 따른 고체 입자의 입자 크기는 분말로서 결정된다.All particle sizes of the solid particles according to the present invention are determined by laser diffraction techniques using "Mastersizer 3000 " of Malvern Instruments Ltd. of Great Britain. Further information on this particle size measurement can be found in, for example, "Basic principles of particle size analytics " Malvern Instruments Limited, Enigma Business Part, Grovewood Road, Malvern, Worcestershire, WR14 1XZ, UK) and the "Manual of Malvern particle size analyzer". Particular reference has been made to the user's manual "MAN 0096 1.0, 1994, November ". Unless otherwise stated, all particle sizes for the coarse particles of the solid particles according to the present invention have a Dv90 value determined by laser diffraction (volume diameter, 90% of the distribution down this point, 10% above). The particle size can be determined in the form of a dry (i.e., powder) or suspension. Preferably, the particle size of the solid particles according to the invention is determined as a powder.
또한, 고체 입자의 입자 크기의 분포는 본 발명의 필수적인 특징이 아니다.In addition, the distribution of the particle size of the solid particles is not an essential feature of the present invention.
또한, 고체 입자의 형태도 본 발명의 필수적인 특징이 아니다. 형태는 구형 또는 임의의 다른 형태(또한 형태들의 혼합)일 수 있다. 일반적으로, 바람직하게는, 입자는 구형이다.In addition, the shape of the solid particles is not an essential feature of the present invention. The shape may be spherical or any other shape (also a mixture of shapes). Generally, the particles are preferably spherical.
입자는, 그러한 입자 제조에 사용되는 흔히 공지된 임의의 공정(분무 건조, 분무 냉각(spray chilling) 등)에 의해 제조될 수 있다.The particles can be prepared by any of the commonly known processes used for producing such particles (spray drying, spray chilling, etc.).
이러한 작은 입자를 코팅하는 방법은 잘 알려져 있다. 이는 일반적으로 유동층 분무 과립화(fluidized bed spray granulation), 필름 코팅 또는 습식 과립화에 의해 수행된다.Methods for coating such small particles are well known. This is generally carried out by fluidized bed spray granulation, film coating or wet granulation.
본 발명에 따른 고체 입자는 주로 압축된 정제 제조에 사용된다.The solid particles according to the invention are mainly used in the production of compressed tablets.
따라서, 본 발명은, 압축된 정제의 제조에서의, 하나 이상의 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6), (SP7), (SP7'), (SP7''), (SP8), (SP9), (SP10) 및/또는 (SP11)의 용도에 관한 것이다.(SP), (SP), (SP2), (SP3), (SP4), (SP5) and (SP6) in the production of compressed tablets, , SP7, SP7 ', SP7 ", SP8, SP9, SP10 and / or SP11.
정제 제조에 사용되는 압력은 5 kN 이상이다.The pressure used to make the tablet is 5 kN or more.
정제 제조에 사용되는 압력은 일반적으로 5 내지 40 kN, 바람직하게는 10 내지 40 kN, 더욱 바람직하게는 15 내지 40 kN이다.The pressure used for preparing the tablets is generally 5 to 40 kN, preferably 10 to 40 kN, more preferably 15 to 40 kN.
따라서, 본 발명은, 하나 이상의 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6), (SP7), (SP7'), (SP7''), (SP8), (SP9), (SP10) 및/또는 (SP11)가 적어도 5 kN의 압력에서 압축되는, 압축된 정제 제조 공정 (P)에 관한 것이다.Accordingly, the present invention is directed to a method of preparing a solid particle dispersion composition comprising at least one solid particle SP, SP ',
따라서, 본 발명은, 하나 이상의 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6), (SP7), (SP7'), (SP7''), (SP8), (SP9), (SP10) 및/또는 (SP11)가 5 내지 40 kN의 압력에서 압축되는, 압축된 정제 제조 공정 (P')에 관한 것이다.Accordingly, the present invention is directed to a method of preparing a solid particle dispersion composition comprising at least one solid particle SP, SP ',
따라서, 본 발명은, 하나 이상의 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6), (SP7), (SP7'), (SP7''), (SP8), (SP9), (SP10) 및/또는 (SP11)가 10 내지 40 kN의 압력에서 압축되는, 압축된 정제 제조 공정 (P'')에 관한 것이다.Accordingly, the present invention is directed to a method of preparing a solid particle dispersion composition comprising at least one solid particle SP, SP ',
따라서, 본 발명은, 하나 이상의 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6), (SP7), (SP7'), (SP7''), (SP8), (SP9), (SP10) 및/또는 (SP11)가 15 내지 40 kN의 압력에서 압축되는, 압축된 정제 제조 공정 (P''')에 관한 것이다.Accordingly, the present invention is directed to a method of preparing a solid particle dispersion composition comprising at least one solid particle SP, SP ',
또한, 입자를 정제로 압축시키기 전에, 본 발명에 따른 고체 입자에 추가적인 임의의 재료(예컨대 충전제, 염료, 항산화제, 향료 등)를 첨가하는 것도 가능하다.It is also possible to add any additional materials (such as fillers, dyes, antioxidants, perfumes, etc.) to the solid particles according to the present invention before compressing the particles into tablets.
따라서, 본 발명은, 하나 이상의 추가 요소가 첨가되는 공정 (P), (P'), (P'') 또는 (P''')인, 공정 (P1)에 관한 것이다.Accordingly, the present invention relates to a process (P1), wherein the process (P), (P '), (P' ') or (P' '') in which one or more additional elements are added.
상기 정제는 건강 보조 식품 또는 의약품일 수 있다. 이는 상기 압축된 정제에 무엇이 추가적으로 첨가되었는지에 의존한다.The tablet may be a health supplement or a medicament. This depends on what is additionally added to the compressed tablet.
나아가, 본 발명은 또한, 하나 이상의 고체 입자 (SP), (SP'), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6), (SP7), (SP7'), (SP7''), (SP8), (SP9), (SP10) 및/또는 (SP11)을 포함하는 압축된 정제에 관한 것이다.Further, the present invention is also directed to a process for the preparation of a solid particulate composition comprising at least one solid particle (SP), (SP '), (SP1), (SP2), (SP3), (SP4), (SP5), (SP6) '), (SP7' '), (SP8), (SP9), (SP10) and / or (SP11).
본 발명은 하기 실시예에 의해 설명된다. 모든 온도는 ℃로 주어지고, 모든 부(parts) 및 백분율은 중량에 관한 것이다.The invention is illustrated by the following examples. All temperatures are given in degrees Celsius, and all parts and percentages are by weight.
실시예Example
실시예 1: 식품용 변성 전분 및 트레할로스 Example 1 : Food modified starch and trehalose
370.6 g의 탈이온수를 용기 내에서 60 ℃ 내지 65 ℃로 가열하였다. 316.75 g의 식품용 변성 전분 및 121.2 g의 트레할로스를 첨가하고 혼합물을 60 내지 65 ℃에서 교반하면서 용액이 되게 하였다. 수득된 용액을 50 내지 55 ℃로 식히고 1시간 동안 탈기하였다. 이때, 190.82 g의 오일 혼합물(180.78 g 비타민 A 아세테이트, 5.02 g BHT 및 5.02 g dl-알파-토코페롤)을 매트릭스 시스템에 첨가하고 유화시켰다. 공정의 온도는 항상 65 ℃ 미만으로 유지하였다. 유화 후에, 유제(emulsion)의 내부 상은 약 272 nm의 평균 입자 크기(Dv(0.1) = 100 nm, Dv(0.5) = 272 nm, Dv(0.9) = 559 nm)를 가졌고, 측정은 레이저 회절(맬베른 3000)에 의해 실현되었다. 유화 후에, 할로겐 수분 분석기(메틀러 톨레도(Mettler Toledo), 타입 HR73-P)에 의해 결정되는 유제의 수분을 확인하고 필요한 경우 조정하였다. 그 후에, 회전식 분무 노즐을 사용하여, 1500 g의 옥수수 전분을 함유하는 분무 팬 내로 유제 150 g을 분무하였다. 수득된 입자를 초과량의 옥수수 전분으로부터 여과해내고(150 내지 600 ㎛), 공기 스트림을 사용하여 실온에서 건조시켰다. 건조 후 최종 생성물 입자 크기는, 레이저 회절(맬베른 3000)로 측정시, 평균 246 ㎛(Dv(0.1) = 198 ㎛, Dv(0.5) = 246 ㎛, Dv(0.9) = 303 ㎛)였다. 표 1에 나열된 바와 같은 조성을 갖는 고체 입자가 수득되었다.370.6 g of deionized water was heated in a vessel to 60 < 0 > C to 65 < 0 > C. 316.75 g of food modified starch and 121.2 g of trehalose were added and the mixture was made to be a solution at 60 to 65 DEG C with stirring. The resulting solution was cooled to 50-55 < 0 > C and degassed for 1 hour. At this time, 190.82 g of an oil mixture (180.78 g vitamin A acetate, 5.02 g BHT and 5.02 g dl-alpha-tocopherol) was added to the matrix system and emulsified. The temperature of the process was always kept below 65 ° C. After emulsification the internal phase of the emulsion had an average particle size of about 272 nm (Dv (0.1) = 100 nm, Dv (0.5) = 272 nm, Dv (0.9) = 559 nm) Malvern 3000). After emulsification, the moisture of the emulsion determined by a halogen moisture analyzer (Mettler Toledo, type HR73-P) was checked and adjusted if necessary. Thereafter, 150 g of an emulsion was sprayed into a spray pan containing 1500 g of corn starch, using a rotary atomizing nozzle. The resulting particles were filtered from an excess of corn starch (150 to 600 mu m) and dried at room temperature using an air stream. The final product particle size after drying was 246 占 퐉 (Dv (0.1) = 198 占 퐉, Dv (0.5) = 246 占 퐉, Dv (0.9) = 303 占 퐉) on average by laser diffraction (Malvern 3000). Solid particles having the compositions listed in Table 1 were obtained.
실시예 2: 식품용 변성 전분 및 트레할로스 Example 2 : Food modified starch and trehalose
381 g의 탈이온수를 용기 내에서 60 ℃ 내지 65 ℃로 가열하였다. 316.75 g의 식품용 변성 전분 및 122.2 g의 트레할로스를 첨가하고 혼합물을 60 내지 65 ℃에서 교반하면서 용액이 되게 하였다. 수득된 용액을 50 내지 55 ℃로 식히고 1시간 동안 탈기하였다. 이때, 190.78 g의 비타민 A 아세테이트를 매트릭스 시스템에 첨가하고 유화시켰다. 공정의 온도는 항상 65 ℃ 미만으로 유지하였다. 유화 후에, 유제의 내부 상은 약 333 nm의 평균 입자 크기(Dv(0.1) = 175 nm, Dv(0.5) = 333 nm, Dv(0.9) = 558 nm)를 가졌고, 측정은 레이저 회절(맬베른 3000)에 의해 실현되었다. 유화 후에, 할로겐 수분 분석기(메틀러 톨레도, 타입 HR73-P)에 의해 결정되는 유제의 수분을 확인하고 필요한 경우 조정하였다. 그 후에, 회전식 분무 노즐을 사용하여, 1500 g의 옥수수 전분을 함유하는 분무 팬 내로 유제 150 g을 분무하였다. 수득된 입자를 초과량의 옥수수 전분으로부터 여과시키고(150 내지 600 ㎛) 공기 스트림을 사용하여 실온에서 건조시켰다. 건조 후 최종 생성물 입자 크기는, 레이저 회절(맬베른 3000)로 측정시, 평균 180 ㎛(Dv(0.1) = 180 ㎛, Dv(0.5) = 240 ㎛, Dv(0.9) = 321 ㎛)였다. 표 2에 나열된 바와 같은 조성을 갖는 고체 입자가 수득되었다.381 g of deionized water was heated in a vessel to 60 to 65 占 폚. 316.75 g of food grade modified starch and 122.2 g of trehalose were added and the mixture was made to be a solution while stirring at 60 to 65 ° C. The resulting solution was cooled to 50-55 < 0 > C and degassed for 1 hour. At this time, 190.78 g of vitamin A acetate was added to the matrix system and emulsified. The temperature of the process was always kept below 65 ° C. After emulsification the internal phase of the emulsion had an average particle size of about 333 nm (Dv (0.1) = 175 nm, Dv (0.5) = 333 nm, Dv (0.9) = 558 nm) ). After emulsification, the moisture of the emulsion determined by a halogen moisture analyzer (METTLER TOLEDO, type HR73-P) was checked and adjusted if necessary. Thereafter, 150 g of an emulsion was sprayed into a spray pan containing 1500 g of corn starch, using a rotary atomizing nozzle. The resulting particles were filtered from excess corn starch and dried at room temperature using an air stream (150-600 mu m). The final product particle size after drying was an average of 180 占 퐉 (Dv (0.1) = 180 占 퐉, Dv (0.5) = 240 占 퐉 and Dv (0.9) = 321 占 퐉) as measured by laser diffraction (Malvern 3000). Solid particles having the compositions listed in Table 2 were obtained.
실시예 3: 식품용 변성 전분 및 수크로스 Example 3 : Food modified starch and sucrose
370.6 g의 탈이온수를 용기 내에서 60 ℃ 내지 65 ℃로 가열하였다. 317.4 g의 식품용 변성 전분 및 122.1 g의 트레할로스를 첨가하고 혼합물을 60 내지 65 ℃에서 교반하면서 용액이 되게 하였다. 수득된 용액을 50 내지 55 ℃로 식히고 1시간 동안 탈기하였다. 이때, 197.3 g의 오일 혼합물(186.9 g 비타민 A 아세테이트, 10.4 g BHT)을 매트릭스 시스템에 첨가하고 유화시켰다. 공정의 온도는 항상 65 ℃ 미만으로 유지하였다. 유화 후에, 유제의 내부 상은 약 276 nm의 평균 입자 크기(Dv(0.1) = 112 nm, Dv(0.5) = 276 nm, Dv(0.9) = 516 nm)를 가졌고, 측정은 레이저 회절(맬베른 3000)에 의해 실현되었다. 유화 후에, 할로겐 수분 분석기(메틀러 톨레도, 타입 HR73-P)에 의해 결정되는 유제의 수분을 확인하고 필요한 경우 조정하였다. 그 후에, 회전식 분무 노즐을 사용하여, 1500 g의 옥수수 전분을 함유하는 분무 팬 내로 유제 150 g을 분무하였다. 수득된 입자를 초과량의 옥수수 전분으로부터 여과해내고(150 내지 600 ㎛), 공기 스트림을 사용하여 실온에서 건조시켰다. 건조 후 최종 생성물 입자 크기는, 레이저 회절(맬베른 3000)로 측정시, 평균 272 ㎛(Dv(0.1) = 197 ㎛, Dv(0.5) = 272 ㎛, Dv(0.9) = 377 ㎛)였다. 표 3에 나열된 바와 같은 조성을 갖는 고체 입자가 수득되었다.370.6 g of deionized water was heated in a vessel to 60 < 0 > C to 65 < 0 > C. 317.4 grams of food grade modified starch and 122.1 grams of trehalose were added and the mixture was allowed to stir while stirring at 60-65 占 폚. The resulting solution was cooled to 50-55 < 0 > C and degassed for 1 hour. At this time, 197.3 g of an oil mixture (186.9 g vitamin A acetate, 10.4 g BHT) was added to the matrix system and emulsified. The temperature of the process was always kept below 65 ° C. After emulsification, the internal phase of the emulsion had an average particle size of about 276 nm (Dv (0.1) = 112 nm, Dv (0.5) = 276 nm, Dv (0.9) = 516 nm) ). After emulsification, the moisture of the emulsion determined by a halogen moisture analyzer (METTLER TOLEDO, type HR73-P) was checked and adjusted if necessary. Thereafter, 150 g of an emulsion was sprayed into a spray pan containing 1500 g of corn starch, using a rotary atomizing nozzle. The resulting particles were filtered from an excess of corn starch (150 to 600 mu m) and dried at room temperature using an air stream. The final product particle size after drying was 272 占 퐉 (Dv (0.1) = 197 占 퐉, Dv (0.5) = 272 占 퐉, Dv (0.9) = 377 占 퐉) as measured by laser diffraction (Malvern 3000). Solid particles having the compositions listed in Table 3 were obtained.
실시예 4: 검 아카시아 및 트레할로스 Example 4 : Sword acacia and trehalose
381 g의 탈이온수를 용기 내에서 60 ℃ 내지 65 ℃로 가열하였다. 143.78 g의 식품용 변성 전분 및 287.56 g의 트레할로스를 첨가하고 혼합물을 60 내지 65 ℃에서 교반하면서 용액이 되게 하였다. 수득된 용액을 50 내지 55 ℃로 식히고 1시간 동안 탈기하였다. 이때, 187.68 g의 오일 혼합물(177.80 g 비타민 A 아세테이트, 4.94 g BHT 및 4.94 g dl-알파-토코페롤)을 매트릭스 시스템에 첨가하고 유화시켰다. 공정의 온도는 항상 65 ℃ 미만으로 유지하였다. 유화 후에, 유제의 내부 상은 약 493 nm의 평균 입자 크기(Dv(0.1) = 215 nm, Dv(0.5) = 493 nm, Dv(0.9) = 987 nm)를 가졌고, 측정은 레이저 회절(맬베른 3000)에 의해 실현되었다. 유화 후에, 할로겐 수분 분석기(메틀러 톨레도, 타입 HR73-P)에 의해 결정되는 유제의 수분을 확인하고 필요한 경우 조정하였다. 그 후에, 회전식 분무 노즐을 사용하여, 1500 g의 옥수수 전분을 함유하는 분무 팬 내로 유제 150 g을 분무하였다. 수득된 입자를 초과량의 옥수수 전분으로부터 여과해내고(150 내지 600 ㎛), 공기 스트림을 사용하여 실온에서 건조시켰다. 건조 후 최종 생성물 입자 크기는, 레이저 회절(맬베른 3000)로 측정시, 평균 234 ㎛(Dv(0.1) = 189 ㎛, Dv(0.5) = 234 ㎛, Dv(0.9) = 293 ㎛)였다. 표 4에 나열된 바와 같은 조성을 갖는 고체 입자가 수득되었다.381 g of deionized water was heated in a vessel to 60 to 65 占 폚. 143.78 g of food grade modified starch and 287.56 g of trehalose were added and the mixture was made to be a solution at 60 to 65 DEG C with stirring. The resulting solution was cooled to 50-55 < 0 > C and degassed for 1 hour. At this time, 187.68 g of an oil mixture (177.80 g vitamin A acetate, 4.94 g BHT and 4.94 g dl-alpha-tocopherol) was added to the matrix system and emulsified. The temperature of the process was always kept below 65 ° C. After emulsification, the internal phase of the emulsion had an average particle size (Dv (0.1) = 215 nm, Dv (0.5) = 493 nm, Dv (0.9) = 987 nm) of about 493 nm and measurements were made by laser diffraction ). After emulsification, the moisture of the emulsion determined by a halogen moisture analyzer (METTLER TOLEDO, type HR73-P) was checked and adjusted if necessary. Thereafter, 150 g of an emulsion was sprayed into a spray pan containing 1500 g of corn starch, using a rotary atomizing nozzle. The resulting particles were filtered from an excess of corn starch (150 to 600 mu m) and dried at room temperature using an air stream. The final product particle size after drying was 234 占 퐉 (Dv (0.1) = 189 占 퐉, Dv (0.5) = 234 占 퐉, Dv (0.9) = 293 占 퐉) as measured by laser diffraction (Malvern 3000). Solid particles having the compositions listed in Table 4 were obtained.
실시예 5: 압축 정제에서의 안정성 Example 5 : Stability in Compression Tablets
27 g의 비타민 A 아세테이트 입자(실시예 1에서 수득된 것), 33.24 g의 미세결정질 셀룰로스, 49.86 g 칼슘 포스페이트 및 0.2 g의 마그네슘 스테아레이트로 이루어진 100 g의 분말을 10분 동안 혼합하였다. 이후, 이 최종 제제를 35 kN의 압력으로 압축시켰다. 정제(보통 디스크-형태임; 0.2 g)을 닫힌 갈색 유리병에 실온에서 저장하고, 1, 7 및 35일의 저장 후에 비타민 A 아세테이트 함량을 결정하였다.100 g of powder consisting of 27 g of vitamin A acetate particles (obtained in Example 1), 33.24 g of microcrystalline cellulose, 49.86 g of calcium phosphate and 0.2 g of magnesium stearate was mixed for 10 minutes. This final formulation was then compressed to a pressure of 35 kN. The tablets (usually disk-shaped; 0.2 g) were stored in a closed glass vial at room temperature and the vitamin A acetate content after 1, 7 and 35 days storage was determined.
본 발명에 따른 입자의 우수한 성질을 보여주기 위한 목적으로, 트레할로스 또는 수크로스 대신에, 비환원당이 아닌 다른 당이 사용된 비교예도 또한 수행하였다. 이 비교용 고체 입자는 실시예 1에 기재된 바와 같이 제조되었다.For the purpose of showing the excellent properties of the particles according to the invention, a comparative example in which a sugar other than non-reducing sugar was used instead of trehalose or sucrose was also carried out. These comparative solid particles were prepared as described in Example 1.
트레할로스의 사용의 영향은 다른 종류의 가소제보다 훨씬 우수하다. 이는 도 1, 2, 및 3 상에서 확인할 수 있다(표 5 내지 7에, 고체 입자가 나열되어 있다. 성분들의 농도는 실시예 1에서와 같다).The effect of using Trehalose is far superior to other plasticizers. This can be confirmed on figures 1, 2 and 3 (solid particles are listed in Tables 5 to 7. Concentrations of the components are the same as in Example 1).
Claims (10)
(ii) 하나 이상의 유화제, 및
(iii) 하나 이상의 비환원당(non-reducing sugar)
을 포함하는 고체 입자.(i) at least 20% by weight, based on the total weight of the solid particles, of at least one fat soluble vitamin,
(ii) at least one emulsifier, and
(iii) at least one non-reducing sugar,
≪ / RTI >
상기 고체 입자의 총 중량을 기준으로 5 내지 55 중량%의 하나 이상의 비환원당(바람직하게는 트레할로스)을 포함하는 고체 입자.The method according to claim 1,
5 to 55% by weight, based on the total weight of the solid particles, of at least one non-reducing sugar (preferably trehalose).
상기 고체 입자의 총 중량을 기준으로 10 내지 50 중량%의 하나 이상의 비환원당을 포함하는 고체 입자.The method according to claim 1,
10 to 50 weight percent of at least one non-reducing sugar based on the total weight of the solid particles.
상기 지용성 비타민이 비타민 A 및 이의 유도체(예컨대 비타민 A 아세테이트 또는 비타민 A 팔미테이트)로 이루어진 군으로부터 선택되는, 고체 입자.4. The method according to any one of claims 1 to 3,
Wherein the fat soluble vitamin is selected from the group consisting of vitamin A and derivatives thereof (e.g., vitamin A acetate or vitamin A palmitate).
상기 고체 입자의 총 중량을 기준으로 20 내지 75 중량%의 하나 이상의 지용성 비타민을 포함하는 고체 입자.5. The method according to any one of claims 1 to 4,
20 to 75% by weight, based on the total weight of the solid particles, of at least one fat soluble vitamin.
상기 고체 입자의 총 중량을 기준으로 25 내지 70 중량%의 하나 이상의 지용성 비타민을 포함하는 고체 입자.6. The method according to any one of claims 1 to 5,
25 to 70% by weight, based on the total weight of the solid particles, of at least one fat soluble vitamin.
상기 고체 입자의 총 중량을 기준으로 20 내지 70 중량%의 하나 이상의 유화제를 포함하는 고체 입자7. The method according to any one of claims 1 to 6,
Based on the total weight of the solid particles, 20 to 70% by weight of at least one emulsifier,
상기 하나 이상의 유화제가
식품용 변성 전분; 아스코르빌 팔미테이트; 펙틴; 알기네이트; 카라기닌; 푸르셀라란; 덱스트린 유도체; 셀룰로스 및 셀룰로스 유도체(예컨대 셀룰로스 아세테이트, 메틸 셀룰로스, 히드록시프로필 메틸 셀룰로스); 리그노술포네이트; 다당류(polysaccharide) 검(예컨대 검 아카시아(= 아라비아 고무), 변성 검 아카시아, TIC 검, 플랙씨드(flaxseed) 검, 가티 검, 타마린드 검 및 아라비노갈락탄); 젤라틴(소, 생선, 돼지, 가금류); 식물성 단백질(예컨대 예를 들면 완두콩, 대두, 피마자 콩, 목화, 감자, 고구마, 카사바, 평지씨, 해바라기, 참깨, 아마씨, 홍화씨, 렌틸, 견과, 밀, 쌀, 옥수수, 보리, 호밀, 귀리, 루핀 및 수수); 우유 또는 유청 단백질을 비롯한 동물성 단백질; 레시틴; 지방산의 폴리글리세롤 에스터; 지방산의 모노글리세리드; 지방산의 다이글리세리드; 소르비탄 에스터; 및 당 에스터(뿐만 아니라 이들의 유도체들)로 이루어진 군으로부터 선택되는,
고체 입자.8. The method according to any one of claims 1 to 7,
Wherein the at least one emulsifier comprises
Modified starch for food; Ascorbyl palmitate; pectin; Alginate; Carrageenin; Furcellaran; Dextrin derivatives; Cellulose and cellulose derivatives (such as cellulose acetate, methylcellulose, hydroxypropylmethylcellulose); Lignosulfonates; Polysaccharide gums (e.g., gum acacia (= gum arabic), modified gum acacia, TIC gum, flaxseed gum, guti gum, tamarind gum and arabinogalactan); Gelatin (cattle, fish, pigs, poultry); Vegetable protein such as peas, soybeans, cassia beans, cotton, potatoes, sweet potatoes, cassava, rapeseed, sunflower, sesame, flaxseed, safflower, lentils, nuts, wheat, rice, corn, barley, rye, And sorghum); Animal proteins, including milk or whey proteins; lecithin; Polyglycerol esters of fatty acids; Monoglycerides of fatty acids; Diglycerides of fatty acids; Sorbitan esters; And sugar esters (as well as derivatives thereof).
Solid particles.
A compressed tablet comprising at least one solid particle according to any one of claims 1 to 8.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15199204 | 2015-12-10 | ||
EP15199204.7 | 2015-12-10 | ||
PCT/EP2016/080421 WO2017097974A1 (en) | 2015-12-10 | 2016-12-09 | Vitamin formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20180091007A true KR20180091007A (en) | 2018-08-14 |
Family
ID=54849478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020187015954A KR20180091007A (en) | 2015-12-10 | 2016-12-09 | Vitamin Formulation |
Country Status (7)
Country | Link |
---|---|
US (2) | US11696594B2 (en) |
EP (1) | EP3386320A1 (en) |
JP (1) | JP6930537B2 (en) |
KR (1) | KR20180091007A (en) |
CN (1) | CN108366605A (en) |
BR (1) | BR112018011476B1 (en) |
WO (1) | WO2017097974A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200007822A (en) * | 2017-05-19 | 2020-01-22 | 디에스엠 아이피 어셋츠 비.브이. | Solid particles |
JP7315287B2 (en) * | 2018-04-27 | 2023-07-26 | ディーエスエム アイピー アセッツ ビー.ブイ. | powder formulation |
CN112105268A (en) * | 2018-04-27 | 2020-12-18 | 帝斯曼知识产权资产管理有限公司 | Powder composition comprising a carotenoid and/or a derivative thereof, a D-glucose oligomer and a modified polysaccharide, and food, feed or personal care formulation comprising such a composition |
US20240108032A1 (en) * | 2019-10-11 | 2024-04-04 | Dsm Ip Assets B.V. | New feed additives of fat-soluble vitamins |
WO2022078924A1 (en) * | 2020-10-12 | 2022-04-21 | Dsm Ip Assets B.V. | New feed additives of fat-soluble vitamins |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5938990A (en) * | 1994-07-01 | 1999-08-17 | Roche Vitamins Inc. | Encapsulation of oleophilic substances and compositions produced thereby |
CN1150892C (en) * | 1998-08-25 | 2004-05-26 | 巴斯福健康与营养学有限公司 | Fish gelatinous composition for use as an ingredient in tablets |
DE60014255T2 (en) * | 1999-07-06 | 2005-11-03 | Dsm Ip Assets B.V. | Composition containing fat-soluble substances in a carbohydrate matrix |
CN1101151C (en) * | 2000-05-01 | 2003-02-12 | 湖南金健米业股份有限公司 | Method for producing antistaling instant rice-flour noodles |
US20060252761A1 (en) * | 2001-03-29 | 2006-11-09 | Michael Davis | Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine |
CN100365988C (en) | 2004-01-09 | 2008-01-30 | 华为技术有限公司 | Session connection resource management optimizing method |
DE102004006106A1 (en) * | 2004-02-06 | 2005-08-25 | Basf Ag | Process for the preparation of dry powders of one or more carotenols |
DE102004046026A1 (en) | 2004-09-21 | 2006-03-23 | Basf Ag | Process for the preparation of dry powders of one or more carotenoids |
JP2008528774A (en) * | 2005-02-02 | 2008-07-31 | ディーエスエム アイピー アセッツ ビー.ブイ. | Powder composition |
DE102005030952A1 (en) * | 2005-06-30 | 2007-01-18 | Basf Ag | Process for the preparation of an aqueous suspension and a pulverulent preparation of one or more carotenoids |
JP4864369B2 (en) * | 2005-07-21 | 2012-02-01 | 第一三共ヘルスケア株式会社 | Method for stabilizing thiamines |
WO2007042153A1 (en) * | 2005-10-11 | 2007-04-19 | Bayer Consumer Care Ag | Mixture of iron and copper salts masking mettalic taste |
WO2007045488A1 (en) * | 2005-10-21 | 2007-04-26 | Dsm Ip Assets B.V. | Novel formulations of fat-soluble active ingredients with high bioavailability |
US20090105331A1 (en) * | 2006-02-06 | 2009-04-23 | David Schaffner | Compositions of active ingredients |
CA2689445A1 (en) * | 2006-06-01 | 2007-12-06 | Sakura Properties, Llc | Fucoidan compositions and methods |
JP5256041B2 (en) * | 2006-10-31 | 2013-08-07 | 株式会社カネカ | Biologically active substance-containing particulate composition and method for producing the same |
EP2118146B1 (en) * | 2007-03-15 | 2019-03-20 | DSM IP Assets B.V. | Carotenoid compositions containing modified gum acacia |
KR20100047869A (en) * | 2007-07-19 | 2010-05-10 | 디에스엠 아이피 어셋츠 비.브이. | Tablettable formulations of lipophilic health ingredients |
US20110052707A1 (en) * | 2008-02-12 | 2011-03-03 | Neil Robert Buck | Combination of vitamin d and 25-hydroxyvitamin d 3 |
JP2012523433A (en) * | 2009-04-10 | 2012-10-04 | アブラクシス バイオサイエンス, エルエルシー | Nanoparticle formulations and uses thereof |
WO2011009015A1 (en) * | 2009-07-16 | 2011-01-20 | Mallinckrodt Inc. | (+) - morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
CN102319263B (en) * | 2011-08-17 | 2013-04-17 | 江门市新会区光华生物科技有限公司 | Film coated tablets containing a plurality of vitamins and mineral matters, and its preparation process |
BR112014009003B1 (en) * | 2011-10-14 | 2019-09-24 | Dsm Ip Assets B.V. | COATING SYSTEM UNDERSTANDING A LIPID COMPOUND, GUM WITH EMULSIFICATION PROPERTIES AND HYDROCOLOID, COMPOSITION WITH A CORE UNDERSTANDING A FAT SOLUBLE COMPOUND, USE OF THIS COMPOSITION AND PRODUCTS UNDERSTANDING SUCH COMPOSITION |
-
2016
- 2016-12-09 WO PCT/EP2016/080421 patent/WO2017097974A1/en active Application Filing
- 2016-12-09 CN CN201680070628.6A patent/CN108366605A/en active Pending
- 2016-12-09 JP JP2018525440A patent/JP6930537B2/en active Active
- 2016-12-09 EP EP16809379.7A patent/EP3386320A1/en active Pending
- 2016-12-09 KR KR1020187015954A patent/KR20180091007A/en not_active Application Discontinuation
- 2016-12-09 US US15/775,425 patent/US11696594B2/en active Active
- 2016-12-09 BR BR112018011476-6A patent/BR112018011476B1/en active IP Right Grant
-
2023
- 2023-05-19 US US18/199,700 patent/US20230284667A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112018011476A2 (en) | 2018-12-04 |
JP2019502658A (en) | 2019-01-31 |
WO2017097974A1 (en) | 2017-06-15 |
BR112018011476B1 (en) | 2022-04-12 |
JP6930537B2 (en) | 2021-09-01 |
EP3386320A1 (en) | 2018-10-17 |
US11696594B2 (en) | 2023-07-11 |
CN108366605A (en) | 2018-08-03 |
US20180343909A1 (en) | 2018-12-06 |
US20230284667A1 (en) | 2023-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230284667A1 (en) | Vitamin formulation | |
CN103874422B (en) | Coat system | |
JP2016511271A (en) | Oral nutrition and pharmaceutical composition for veterinary medicine | |
JP5324755B2 (en) | Particulate composition and method for producing the same | |
JP2015172070A (en) | Film coating composition from solid powder compounds | |
KR20140146662A (en) | Solid, color-stable l-ascorbic acid compositions | |
JPWO2005092124A1 (en) | Method for producing health food containing dietary fiber | |
JP2020520894A (en) | Solid particles | |
JP5557081B2 (en) | Fixed film raw material composition | |
CN108392473A (en) | A kind of formula and preparation method thereof of the stable freeze-dried preparation containing active oil | |
JP2009513612A5 (en) | ||
JP2006213601A (en) | Ubidecarenone-containing powdery meterial and method for producing the same | |
JP7506726B2 (en) | Solid particles | |
CA2925188C (en) | Solid compositions based on minerals and orally disintegrating formulations containing the same | |
US20230309595A1 (en) | Dietary supplement compositions comprising ganoderma and methods for making | |
WO2022078823A1 (en) | Nutraceutical or pharmaceutical composition comprising a modified starch | |
US20040121154A1 (en) | Pellets and process for production thereof | |
JP5780293B2 (en) | New coating system | |
KR20140116512A (en) | Beadlets comprising hop acid salts in a starch matrix | |
CN108283215B (en) | Dispersible solid preparation for fruit preservation and application thereof | |
JP2003144528A (en) | Multilayer tablet and manufacturing method thereof | |
KR20140074738A (en) | Composite containing silymarin, and orally ingestible composition including the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal |